Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 26,944 full-time employees. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. The company works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
06/30/2026
03/31/2026
12/31/2025
09/30/2025
06/30/2025
Revenue
332,279
80,998
75,464
87,534
88,283
85,721
Revenue Growth (YoY)
-1%
-6%
-12%
4%
10%
11%
Cost of Revenue
128,168
33,851
32,127
30,953
31,237
28,075
Gross Profit
204,111
47,147
43,337
56,581
57,046
57,646
Selling, General & Admin
61,390
16,516
14,468
15,885
14,521
15,035
Research & Development
--
--
--
--
--
--
Operating Expenses
170,373
43,899
42,508
42,646
41,320
40,671
Other Non Operating Income (Expenses)
14,228
3,547
2,864
2,688
3,239
2,903
Pretax Income
40,410
5,533
1,997
15,432
17,448
19,050
Income Tax Expense
8,577
1,177
-216
3,536
4,080
4,951
Net Income
32,222
4,443
2,209
12,099
13,471
14,181
Net Income Growth
-43%
-69%
-86%
-14%
7%
2%
Shares Outstanding (Diluted)
833.58
833.58
833.26
833.26
833.08
833.19
Shares Change (YoY)
0%
0%
0%
0%
0%
0%
EPS (Diluted)
38.67
5.33
2.65
14.52
16.17
17.02
EPS Growth
-43%
-69%
-86%
-14%
7%
2%
Free Cash Flow
--
--
8,412
--
9,920
--
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
61.42%
58.2%
57.42%
64.63%
64.61%
67.24%
Operating Margin
10.15%
4%
1.09%
15.91%
17.81%
19.8%
Profit Margin
9.69%
5.48%
2.92%
13.82%
15.25%
16.54%
Free Cash Flow Margin
--
--
11.14%
--
11.23%
--
EBITDA
54,931
8,614
6,400
19,145
20,772
21,736
EBITDA Margin
16.53%
10.63%
8.48%
21.87%
23.52%
25.35%
D&A For EBITDA
21,193
5,366
5,571
5,210
5,046
4,761
EBIT
33,738
3,248
829
13,935
15,726
16,975
EBIT Margin
10.15%
4%
1.09%
15.91%
17.81%
19.8%
Effective Tax Rate
21.22%
21.27%
-10.81%
22.91%
23.38%
25.98%
Follow-Up Questions
What are Dr Reddy's Laboratories Ltd's key financial statements?
According to the latest financial statement (Form-10K), Dr Reddy's Laboratories Ltd has a total asset of $0, Net loss of $0
What are the key financial ratios for RDY?
Dr Reddy's Laboratories Ltd's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Dr Reddy's Laboratories Ltd's revenue broken down by segment or geography?
Dr Reddy's Laboratories Ltd largest revenue segment is Global Generics, at a revenue of 289,552,000,000 in the most earnings release.For geography, United States is the primary market for Dr Reddy's Laboratories Ltd, at a revenue of 149,351,000,000.
Is Dr Reddy's Laboratories Ltd profitable?
no, according to the latest financial statements, Dr Reddy's Laboratories Ltd has a net loss of $0
Does Dr Reddy's Laboratories Ltd have any liabilities?
no, Dr Reddy's Laboratories Ltd has liability of 0
How many outstanding shares for Dr Reddy's Laboratories Ltd?
Dr Reddy's Laboratories Ltd has a total outstanding shares of 0